Evidence map›Paper›PMID 33901199›Full record

ArticlePloS one2021

Effect of community antiretroviral therapy on treatment outcomes among stable antiretroviral therapy patients in Nigeria: A quasi experimental study.

Patrick Dakum, Juliet Ajav-Nyior, Timothy A Attah, Gbenga A Kayode, Asabe Gomwalk, Helen Omuh, Halima Ibrahim, Mercy Omozuafoh, Abimiku Alash'le, Charles Mensah and 2 more

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Patrick DakumInstitute of Human Virology, Maina Court, Central Business District, Abuja, Nigeria.
Juliet Ajav-NyiorInstitute of Human Virology, Maina Court, Central Business District, Abuja, Nigeria.
Timothy A AttahInstitute of Human Virology, Maina Court, Central Business District, Abuja, Nigeria.ORCID 0000-0003-2131-6488
Gbenga A KayodeInstitute of Human Virology, Maina Court, Central Business District, Abuja, Nigeria.
Asabe GomwalkInstitute of Human Virology, Maina Court, Central Business District, Abuja, Nigeria.
Helen OmuhInstitute of Human Virology, Maina Court, Central Business District, Abuja, Nigeria.
Halima IbrahimInstitute of Human Virology, Maina Court, Central Business District, Abuja, Nigeria.
Mercy OmozuafohInstitute of Human Virology, Maina Court, Central Business District, Abuja, Nigeria.
Abimiku Alash'leInstitute of Human Virology University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Charles MensahInstitute of Human Virology, Maina Court, Central Business District, Abuja, Nigeria.
Young OluokunInstitute of Human Virology, Maina Court, Central Business District, Abuja, Nigeria.
Franca AkolawoleInstitute of Human Virology, Maina Court, Central Business District, Abuja, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study evaluates the effect of Community Anti-retroviral Groups on Immunologic, Virologic and clinical outcomes of stable Antiretroviral Therapy patients in Nigeria.

methodA cohort of 251 eligible adults (≥18 years) on first-line ART for at least 6 months with CD4 counts >200 cells/mm3 and viral load <1000 c/ml were devolved from 10 healthcare facilities to 51 community antiretroviral therapy groups. Baseline immunologic, virologic and clinical parameters were collected and community antiretroviral therapy group patients were followed up for a year after which Human Immunodeficiency Virus treatment outcomes at the baseline and a year after follow-up were compared using paired sample t-test. All the analyses were performed in STATA version 14.

resultOut of the 251 stable antiretroviral therapy adults enrolled, 186 (75.3%) were female, 52 (22.7%) had attained post-secondary education and the mean age of participants was 38 years (SD: 9.5). Also, 66 (27.9%) were employed while 125 (52.7%) were self-employed and 46(19.41%) unemployed. 246 (98.0%) of the participants were retained in care. While there was no statistically significant change in the CD4 counts (456cells/mm3 vs 481cells/mm3 P-0.489) and Log10 viral load (3.54c/ml vs 3.69c/ml P-0.359) after one year of devolvement into the community, we observed a significant increase in body weight (60.8 vs 65, P-0.01).

conclusionThis study demonstrates that community antiretroviral therapy has a potential of maintaining optimum treatment outcomes while improving adherence and retention, and reducing the burden of HIV treatment on the health facility. This study provides baseline information for further research and vital information for HIV program implementers planning to decentralize the management of stable antiretroviral therapy clients.

Indexed as

AdultAnti-HIV AgentsCD4 Lymphocyte CountCommunity Health ServicesFemaleFollow-Up StudiesHIVHIV InfectionsHumansMaleMiddle AgedNigeriaPrevalenceTreatment OutcomeViral LoadWeight GainAnti-HIV Agents

Identifiers

PMID33901199
PMCPMC8075245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.